Meridian Wealth Management, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
Meridian Wealth Management, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q4 2022$65,960
-45.9%
17,000
-66.0%
0.01%
-53.8%
Q3 2022$122,000
-22.8%
50,000
-37.5%
0.01%0.0%
Q2 2022$158,000
-42.5%
80,000
-46.7%
0.01%
-56.7%
Q1 2022$275,000
+29.7%
150,0000.0%0.03%
+30.4%
Q4 2021$212,000
-9.0%
150,000
-27.2%
0.02%
-20.7%
Q3 2021$233,000
-11.1%
206,000
+25.6%
0.03%
-12.1%
Q2 2021$262,000
+48.9%
164,000
+64.0%
0.03%
+26.9%
Q1 2021$176,000
-9.7%
100,0000.0%0.03%
-16.1%
Q4 2020$195,000
+36.4%
100,000
+66.7%
0.03%
-11.4%
Q3 2020$143,000
+146.6%
60,000
+200.0%
0.04%
+84.2%
Q2 2020$58,00020,0000.02%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Prosight Management, LP 883,214$1,722,0000.80%
Telemetry Investments, L.L.C. 200,615$391,0000.66%
Perceptive Advisors 16,584,802$32,340,0000.35%
Consonance Capital Management LP 1,558,290$3,039,0000.28%
683 Capital Management, LLC 2,000,000$3,900,0000.18%
ESSEX INVESTMENT MANAGEMENT CO LLC 627,931$1,224,0000.15%
GSA CAPITAL PARTNERS LLP 327,052$638,0000.10%
APOGEM CAPITAL LLC 54,240$106,0000.07%
HUSSMAN STRATEGIC ADVISORS, INC. 82,000$160,0000.04%
J. Goldman & Co LP 376,319$734,0000.04%
View complete list of ADMA BIOLOGICS INC shareholders